+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Compounding Pharmacy - Global Strategic Business Report

  • PDF Icon

    Report

  • 276 Pages
  • June 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 5309399
The global market for Compounding Pharmacy was estimated at US$14.6 Billion in 2025 and is projected to reach US$22.0 Billion by 2032, growing at a CAGR of 6.0% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Compounding Pharmacy Market - Key Trends and Drivers Summarized

How Are Compounding Pharmacies Tailoring Personalized Medicine for Modern Healthcare?

Compounding pharmacies play a critical role in modern healthcare by providing customized medications tailored to the specific needs of individual patients. Unlike mass-produced pharmaceuticals, compounded medications are created by pharmacists who mix ingredients to form personalized treatments, adjusting dosage forms, strengths, or ingredients based on a patient’s unique requirements. This is particularly important for patients who cannot take commercially available medications due to allergies, difficulty swallowing pills, or specific dosage needs that are not available in mass-produced drugs. Compounded medications are used across a wide range of medical fields, including dermatology, pediatrics, pain management, and hormone replacement therapy. In recent years, the demand for personalized medicine has increased, as patients and healthcare providers seek more precise treatments that cater to individual health conditions. This shift highlights the growing importance of compounding pharmacies in filling the gaps left by standard pharmaceutical manufacturing, offering a personalized approach to medicine that enhances patient care and outcomes.

How Are Technological Advances Revolutionizing Compounding Pharmacy Practices?

The practice of compounding pharmacy has seen significant advancements, driven by cutting-edge technologies that have made the preparation of customized medications more efficient, accurate, and safe. Automation has been one of the most transformative developments, with automated compounding systems allowing for precise measurements of active ingredients, reducing human error, and increasing the speed of production. This is especially crucial in the preparation of sterile compounds, where any contamination can pose significant risks. Furthermore, advancements in pharmaceutical software have enabled compounding pharmacists to streamline their workflows, ensuring more accurate record-keeping, better inventory management, and compliance with regulatory standards. Digital platforms now allow pharmacists to cross-reference drug interactions and patient allergies quickly, further enhancing the safety and efficacy of compounded medications. The use of advanced compounding techniques, such as transdermal gels, rapid-dissolve tablets, and sustained-release formulations, has expanded the range of treatments available to patients, offering more flexible and innovative ways to deliver medications. Additionally, the rise of 3D printing technology in pharmaceuticals is beginning to influence compounding practices, with the potential to print personalized medications in precise dosages and forms, further pushing the boundaries of what can be achieved in tailored treatments. These technological innovations are improving the quality and accessibility of compounded medications, making personalized treatments more scalable and reliable.

How Is Compounding Pharmacy Serving Diverse Healthcare Needs Across Various Fields?

Compounding pharmacies cater to a diverse range of healthcare needs, providing solutions in areas where traditional pharmaceutical products may fall short. In pediatrics, for instance, compounded medications offer tailored dosages that are often unavailable in mass-market drugs, and pharmacists can prepare formulations in liquid, flavored, or chewable forms to make them more palatable for children. In dermatology, compounding pharmacies produce customized creams, ointments, and gels that address specific skin conditions such as psoriasis, eczema, and acne, often blending multiple active ingredients to create a comprehensive treatment in a single product. Pain management is another field where compounding pharmacies are vital, especially for patients with chronic pain who require precise formulations of medications such as opioids, muscle relaxants, or anti-inflammatories in customized doses or delivery methods, such as topical creams or transdermal patches, to minimize systemic side effects. Hormone replacement therapy (HRT) is another area where compounding pharmacies excel, creating individualized doses of bioidentical hormones tailored to the hormonal needs of patients undergoing menopause or other endocrine imbalances. Furthermore, compounding pharmacies are often relied upon in veterinary medicine, where medications for animals must be tailored in terms of dosage and formulation, sometimes flavored to ensure compliance. Across these various fields, compounding pharmacies offer personalized solutions that meet the specific needs of patients who might otherwise struggle to find appropriate treatments through conventional pharmaceuticals.

What Are the Factors Behind the Growth of the Compounding Pharmacy Market?

The growth in the compounding pharmacy market is driven by several factors, reflecting both the evolving needs of healthcare and advancements in pharmaceutical practices. One of the key drivers is the increasing demand for personalized medicine, as patients and healthcare providers seek more individualized treatments tailored to specific conditions, allergies, and preferences. This trend is particularly strong in fields like hormone replacement therapy (HRT), pain management, and pediatric care, where standard dosages and formulations often do not meet patient needs. Another significant factor is the shortage or discontinuation of certain medications from large pharmaceutical manufacturers, which has led healthcare providers to turn to compounding pharmacies to fill the gaps and ensure continued treatment for their patients. Additionally, regulatory changes and concerns about the safety and effectiveness of mass-produced medications, particularly with recalls or drug shortages, have spurred greater reliance on compounding pharmacies to provide alternative solutions. Technological advancements, such as the introduction of automation in compounding processes and enhanced digital tools for managing patient data, are also driving market growth by increasing the efficiency and accuracy of compounded drug production. Furthermore, the rise in healthcare costs and the growing number of aging populations in developed regions are pushing demand for more tailored and affordable treatment options, which compounding pharmacies are uniquely positioned to provide. Lastly, the increasing awareness of compounding’s role in veterinary medicine, offering solutions that are often not available in the traditional pharmaceutical market, is expanding the scope of the compounding pharmacy market. Together, these factors are contributing to the sustained growth of compounding pharmacies as a critical element of personalized healthcare solutions.

Report Scope

The report analyzes the Compounding Pharmacy market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Segment (Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic, Other Segments); Distribution Channel (Hospital Pharmacy, Compounding Pharmacy, Other Distribution Channels)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Pain Management Therapeutic Area segment, which is expected to reach US$6.3 Billion by 2032 with a CAGR of a 7.2%. The Hormone Replacement Therapy Therapeutic Area segment is also set to grow at 5.7% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $4.3 Billion in 2025, and China, forecasted to grow at an impressive 5.7% CAGR to reach $3.9 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Compounding Pharmacy Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Compounding Pharmacy Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Compounding Pharmacy Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as B. Braun SE, Dougherty`s Pharmacy, Inc., Empower Pharmacy, Fagron NV, Fresenius Kabi AG and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Compounding Pharmacy market report include:

  • B. Braun SE
  • Dougherty`s Pharmacy, Inc.
  • Empower Pharmacy
  • Fagron NV
  • Fresenius Kabi AG
  • The London Specialist Pharmacy Ltd.
  • Triangle Compounding Pharmacy, Inc.
  • Village Compounding Pharmacy
  • Walgreen Company
  • Wedgewood Pharmacy LLC

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 557 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • Global Economic Update
  • Compounding Pharmacy - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Chronic Diseases Expands Addressable Market for Customized Compounded Medications
  • Increasing Demand for Personalized Medicine Propels Growth of Compounding Pharmacies
  • Advancements in Pharmaceutical Compounding Strengthen the Business Case for Precision Dosage Solutions
  • Growing Focus on Pediatric and Geriatric Care Spurs Demand for Tailored Compounded Medications
  • Shortages of Commercially Available Drugs Throw the Spotlight on Compounding Pharmacies for Alternative Solutions
  • Rising Demand for Hormone Replacement Therapy (HRT) Accelerates Growth of Compounded Pharmacy Services
  • Emerging Need for Allergen-Free and Preservative-Free Medications Expands Opportunities for Compounding Pharmacies
  • Surge in Demand for Bio-Identical Hormones and Custom Pain Management Solutions Strengthens Business Case for Compounding
  • Rising Focus on Niche Therapies, Including Dermatology and Ophthalmology, Expands Market for Specialty Compounded Medications
  • Technological Innovations in Sterile Compounding Propel Growth of Safe and Efficient Compounded Medication Services
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Compounding Pharmacy Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Compounding Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Pain Management Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Pain Management Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Pain Management Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Hormone Replacement Therapy Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Hormone Replacement Therapy Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Hormone Replacement Therapy Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Dermal Disorders / Dermatology Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Dermal Disorders / Dermatology Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Dermal Disorders / Dermatology Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Oncology / Specialty Drugs Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Oncology / Specialty Drugs Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Oncology / Specialty Drugs Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Pediatrics Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Pediatrics Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Pediatrics Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Veterinary Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Veterinary Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Veterinary Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Adult Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Adult Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Adult Age Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Geriatric Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Geriatric Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Geriatric Age Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Pediatric Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Pediatric Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Pediatric Age Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 35: World Recent Past, Current & Future Analysis for Oral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 36: World Historic Review for Oral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 37: World 13-Year Perspective for Oral Administration Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 38: World Recent Past, Current & Future Analysis for Topical Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 39: World Historic Review for Topical Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 40: World 13-Year Perspective for Topical Administration Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 41: World Recent Past, Current & Future Analysis for Parenteral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 42: World Historic Review for Parenteral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 43: World 13-Year Perspective for Parenteral Administration Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 44: World Recent Past, Current & Future Analysis for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 45: World Historic Review for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 46: World 13-Year Perspective for Other Administration Routes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 47: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 48: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 49: World 13-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 50: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 51: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 52: World 13-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 53: World Recent Past, Current & Future Analysis for Retail / Community Dispensing End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 54: World Historic Review for Retail / Community Dispensing End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 55: World 13-Year Perspective for Retail / Community Dispensing End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 56: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 57: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 58: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
REST OF WORLD
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • B. Braun SE
  • Dougherty`s Pharmacy, Inc.
  • Empower Pharmacy
  • Fagron NV
  • Fresenius Kabi AG
  • The London Specialist Pharmacy Ltd.
  • Triangle Compounding Pharmacy, Inc.
  • Village Compounding Pharmacy
  • Walgreen Company
  • Wedgewood Pharmacy LLC

Table Information